Search research articles
Contact Us
Filters
Showing results (161-170 of 180) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
Shahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
Leukemia
|
March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2005
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group
J Russell Geyer, Richard Sposto, Mark Jennings, et al.
Journal of Community Health
|
June 15, 2015
Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer
Salma Shariff-Marco, Juan Yang, Esther M John, et al.
The Lancet. Oncology
|
July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Journal of Pediatric Hematology/Oncology
|
January 5, 2012
Primary follicular lymphoma of the testis in children and adolescents
Mark A Lones, Martine Raphael, Keith McCarthy, et al.
Leukemia
|
September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Cancer Causes & Control : CCC
|
July 19, 2013
The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival
Anna H Wu, Scarlett Lin Gomez, Cheryl Vigen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas
Anat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 180) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2012
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
Shahab Asgharzadeh, Jill A Salo, Lingyun Ji, et al.
Leukemia
|
March 8, 2019
Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2005
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group
J Russell Geyer, Richard Sposto, Mark Jennings, et al.
Journal of Community Health
|
June 15, 2015
Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer
Salma Shariff-Marco, Juan Yang, Esther M John, et al.
The Lancet. Oncology
|
July 30, 2013
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, et al.
Journal of Pediatric Hematology/Oncology
|
January 5, 2012
Primary follicular lymphoma of the testis in children and adolescents
Mark A Lones, Martine Raphael, Keith McCarthy, et al.
Leukemia
|
September 30, 2018
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
Deepa Bhojwani, Richard Sposto, Nirali N Shah, et al.
Haematologica
|
February 3, 2022
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)
Sarah K Tasian, Lewis B Silverman, James A Whitlock, et al.
Cancer Causes & Control : CCC
|
July 19, 2013
The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival
Anna H Wu, Scarlett Lin Gomez, Cheryl Vigen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas
Anat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Page
of 18